TELA Bio Q1 2026 Earnings EPS Misses Estimates Amid Stock Rally Syndax Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues HTFC Q1 2026 Earnings Narrow EPS Miss Amid Stable Operations VEON Q1 2026 Earnings EPS Beat Underpins Operational Resilience EME Q1 2026 Earnings EPS Surges 1487 Above Estimates Stock Gains Enterprise Financial Services Corporation EFSCP Q1 2026 Earnings Slight EPS Miss Amid Solid Capital Performance